News


Second phase of clinical trial for promising COVID-19 drug begins

May 15, 2020

Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.




Don’t let COVID-19 keep you from getting stroke care

May 13, 2020

Even during the COVID-19 pandemic, patients should never hesitate to call an ambulance if they have signs of a stroke




Remdesivir showing success in combating COVID-19

April 30, 2020

Early results of a COVID-19 treatment study being conducted in San Antonio shows a faster recovery time and fewer deaths for patients.




Scientists research a solution to the metabolic crisis

April 27, 2020

“Millions of people consume too much food, while millions of others are in poverty and subsist on too little food. We are studying what happens at the molecular level in both situations with a goal of developing a drug to intervene,” said Dr. Madesh Muniswamy.




Researchers aim at the heart of COVID-19 cardiac damage

April 20, 2020

To understand and prevent COVID-19-induced heart disease, researchers will follow recovered patients.




A breakthrough in the way blood is stored

April 13, 2020

UT Health San Antonio played a major research role in the FDA’s recent approval of a new process that nearly triples the five-day shelf life of blood platelets, commonly used for treating trauma patients.




Researchers study antibodies against coronavirus

April 1, 2020

As laboratories across the country rush to find answers for the novel coronavirus, UT Health San Antonio is bringing a unique combination of expertise to bear on the crisis.




UT Health San Antonio leads COVID-19 treatment study

March 30, 2020

UT Health San Antonio and University Health System physicians are among the first in the nation to test an investigational drug.




Long-lasting treatment drug could slow the opioid crisis

March 10, 2020

Researchers are developing an anti-opioid drug to protect against overdose for weeks or longer.




CPRIT awards millions for San Antonio cancer research

February 24, 2020

Grants will advance the work of the Center for Innovative Drug Discovery, a research center offered jointly by UT Health San Antonio and UTSA.